CIN/LLPIN/FCRN | U85100GJ2020PTC112901 |
ROC Name | ROC Ahmedabad |
Company Type | Company |
Company Category | Company limited by shares |
Activity Description | EDUCATION |
Active Compliance | - |
Date of Inc | 24 February, 2020 |
Date of AGM | 30 September, 2023 |
Date of B/S | 31 March, 2023 |
Company Status | Active |
CIRP | - |
Address other than R/o | - |
Authorise Capital | 1,00,00,000 |
Paid up capital | 1,00,00,000 |
n******@i****************.com | |
Listing Status | Not Listed |
filling status | - |
Pan | - |
Registered Address | 407, SILVER RADIANCE, PAKWAN CHAR RASTA, SINDHU BHAVAN ROAD, BODAKDEV,, AHMEDABAD, Ahmedabad, Gujarat - 380054, India |
Sr No | DIN | Name | Designation | Begin Date |
---|---|---|---|---|
1 | 03540913 | PANKAJ SINGH | Director | 06 September, 2021 |
2 | 07931885 | GOVINDSINGH BHAVANSINH CHAVDA | Whole-time director | 24 February, 2020 |
3 | 08082565 | VISHAL HARSHVARDHAN JAIN | Director | 06 September, 2021 |
4 | 08563139 | DHRUV DESAI | Additional Director | 20 August, 2024 |
The CIN (Corporate Identification Number) for AMPHINA THERAPEUTICS PRIVATE LIMITED is U85100GJ2020PTC112901.
AMPHINA THERAPEUTICS PRIVATE LIMITED is registered with ROC Ahmedabad.
AMPHINA THERAPEUTICS PRIVATE LIMITED is a Company limited by shares.
The main activity of AMPHINA THERAPEUTICS PRIVATE LIMITED is EDUCATION.
AMPHINA THERAPEUTICS PRIVATE LIMITED was incorporated on 24 February, 2020.
AMPHINA THERAPEUTICS PRIVATE LIMITED is currently Active.
The authorized capital of AMPHINA THERAPEUTICS PRIVATE LIMITED is ₹1,00,00,000.
The paid-up capital of AMPHINA THERAPEUTICS PRIVATE LIMITED is ₹1,00,00,000.
No, AMPHINA THERAPEUTICS PRIVATE LIMITED is not listed on stock exchange.
The registered address of AMPHINA THERAPEUTICS PRIVATE LIMITED is 407, SILVER RADIANCE, PAKWAN CHAR RASTA, SINDHU BHAVAN ROAD, BODAKDEV,, AHMEDABAD, Ahmedabad, Gujarat - 380054, India
There are 4 directors in AMPHINA THERAPEUTICS PRIVATE LIMITED. PANKAJ SINGH, GOVINDSINGH BHAVANSINH CHAVDA, VISHAL HARSHVARDHAN JAIN, and DHRUV DESAI.